1. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia. Issue 3 (4th March 2017) Authors: Vojdeman, Fie Juhl; van't Veer, Mars B.; Tjønnfjord, Geir E.; Itälä-Remes, Maija; Kimby, Eva; Polliack, Aaron; Wu, Ka L.; Doorduijn, Jeanette K.; Alemayehu, Wendimagegn G.; Wittebol, Shulamiet; Kozak, Tomas; Walewski, Jan; Abrahamse-Testroote, Martine C. J.; van Oers, Marinus H. J.; Geisler, Chri... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 3(2017) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies – A population-based study from northern Sweden. (2nd January 2016) Authors: Brandefors, Lena; Kimby, Eva; Lundqvist, Kristina; Melin, Beatrice; Lindh, Jack Journal: Acta oncologica Issue: Volume 55:Number 1(2016) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 15‐year follow‐up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. (5th July 2016) Authors: Eskelund, Christian W.; Kolstad, Arne; Jerkeman, Mats; Räty, Riikka; Laurell, Anna; Eloranta, Sandra; Smedby, Karin E.; Husby, Simon; Pedersen, Lone B.; Andersen, Niels S.; Eriksson, Mikael; Kimby, Eva; Bentzen, Hans; Kuittinen, Outi; Lauritzsen, Grete F.; Nilsson‐Ehle, Herman; Ralfkiær, Elisabet... Journal: British journal of haematology Issue: Volume 175:Number 3(2016) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prophylactic immunoglobulin therapy in secondary immune deficiency – an expert opinion. (1st September 2016) Authors: Agostini, Carlo; Blau, Igor-Wolfgang; Kimby, Eva; Plesner, Torben Journal: Expert review of clinical immunology Issue: Volume 12:Number 9(2016) Page Start: 921 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas. Issue 9 (2nd September 2015) Authors: Kimby, Eva; Östenstad, Björn; Brown, Peter; Hagberg, Hans; Erlanson, Martin; Holte, Harald; Linden, Ola; Johansson, Ann-Sofie; Ahlgren, Tomas; Wader, Karin; Wahlin, Björn Engelbrekt; Delabie, Jan; Sundström, Christer Journal: Leukemia & lymphoma Issue: Volume 56:Issue 9(2015:Sep.) Page Start: 2598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. M7‐FLIPI is not prognostic in follicular lymphoma patients with first‐line rituximab chemo‐free therapy. (18th August 2019) Authors: Lockmer, Sandra; Ren, Weicheng; Brodtkorb, Marianne; Østenstad, Bjørn; Wahlin, Björn E.; Pan‐Hammarström, Qiang; Kimby, Eva Journal: British journal of haematology Issue: Volume 188:Number 2(2020) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non‐Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study. (27th December 2021) Authors: Brandefors, Lena; Sander, Birgitta; Lundqvist, Kristina; Kimby, Eva Journal: British journal of haematology Issue: Volume 196:Number 6(2022) Page Start: 1362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK). (17th August 2020) Authors: Moccia, Alden Alberto; Schär, Sämi; Hayoz, Stefanie; Pirosa, Maria Cristina; Taverna, Christian; Novak, Urban; Kimby, Eva; Ghielmini, Michele; Zucca, Emanuele Journal: British journal of haematology Issue: Volume 192:Number 6(2021) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG). Issue 6 (20th December 2020) Authors: Aurer, Igor; Dreyling, Martin; Federico, Massimo; Tilly, Herve; Linton, Kim; Kimby, Eva; Chamuleau, Martine E. D.; Kersten, Marie Jose Journal: HemaSphere Issue: Volume 4:Issue 6(2020) Page Start: e481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The simplified follicular lymphoma PRIMA‐prognostic index is useful in patients with first‐line chemo‐free rituximab‐based therapy. (14th May 2020) Authors: Kimby, Eva; Lockmer, Sandra; Holte, Harald; Hagberg, Hans; Wahlin, Björn E.; Brown, Peter; Østenstad, Bjørn Journal: British journal of haematology Issue: Volume 191:Number 5(2020) Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗